临床腹泻患者艰难梭菌的感染情况和分子流行特征(4)
[17] Chen YB，Gu SL，Wei ZQ，et al. Molecular epidemiology of Clostridium difficile in a tertiary hospital of china [J]. J Med Microbiol，2014，63(Pt 4)：562-569.
[18] Wang R，Suo L，Chen HX，et al. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People′s Liberation Army General Hospital in China [J]. Int J Infect Dis，2017，67：86-91.
[19] Jin D，Luo Y，Huang C，et al. Molecular Epidemiology of Clostridium difficile Infection in hospitalized Patients in Eastern China [J]. J Clin Microbiol，2017，55(3)：801-810.
[20] 陈丽丹.不同来源的艰难梭菌其毒素、MLST分型及药敏情况的分析[D].广州：南方医科大学，2016.
[21] Wang P，Zhou Y，Wang Z，et al. Identification of Clostridium difficile ribotype 027 for the first time in Mainland China [J]. Infect Control Hosp Epidemiol，2014，35(1)：95-98.
[22] Cheng JW，Xiao M，Kudinha T，et al. The first two Clostridium difficile ribotype 027/ST1 isolates identified in Beijing，China-an emerging problem or a neglected threat？[J].Sci Rep，2016，6：18834.
(收稿日期：2018-07-24 本文編辑：封 华), 百拇医药(冯雪君 徐少毅 吴晓燕)
[18] Wang R，Suo L，Chen HX，et al. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People′s Liberation Army General Hospital in China [J]. Int J Infect Dis，2017，67：86-91.
[19] Jin D，Luo Y，Huang C，et al. Molecular Epidemiology of Clostridium difficile Infection in hospitalized Patients in Eastern China [J]. J Clin Microbiol，2017，55(3)：801-810.
[20] 陈丽丹.不同来源的艰难梭菌其毒素、MLST分型及药敏情况的分析[D].广州：南方医科大学，2016.
[21] Wang P，Zhou Y，Wang Z，et al. Identification of Clostridium difficile ribotype 027 for the first time in Mainland China [J]. Infect Control Hosp Epidemiol，2014，35(1)：95-98.
[22] Cheng JW，Xiao M，Kudinha T，et al. The first two Clostridium difficile ribotype 027/ST1 isolates identified in Beijing，China-an emerging problem or a neglected threat？[J].Sci Rep，2016，6：18834.
(收稿日期：2018-07-24 本文編辑：封 华), 百拇医药(冯雪君 徐少毅 吴晓燕)